| Drug Name | Sarclisa (isatuximab) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Patient Card
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Interference with indirect antiglobulin test |
| Patient card |
|
| Health care provider guide |
|